About: Rethinking Risk-Benefit Assessment for Phase I Cancer Trials

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Rethinking Risk-Benefit Assessment for Phase I Cancer Trials Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
description	artículu científicu (ast) wetenschappelijk artikel (nl) article scientifique publié en 2006 (fr) наукова стаття, опублікована в липні 2006 (uk) 2006ജൂലൈ 1 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം (ml) im Juli 2006 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q58376052-DF9A96A8-8FC8-4FA8-A9F2-09FA507962FC
publication date	2006-07-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58376052-891FD330-BA71-4DE1-9F08-36B4CDA026A8
language of work or name	English
rdfs:label	Rethinking Risk-Benefit Assessment for Phase I Cancer Trials (en) Rethinking Risk-Benefit Assessment for Phase I Cancer Trials (nl)
skos:prefLabel	Rethinking Risk-Benefit Assessment for Phase I Cancer Trials (en) Rethinking Risk-Benefit Assessment for Phase I Cancer Trials (nl)
name	Rethinking Risk-Benefit Assessment for Phase I Cancer Trials (en) Rethinking Risk-Benefit Assessment for Phase I Cancer Trials (nl)
author	wds:Q58376052-09EC161E-5A3E-4860-B879-D99F9CBB615B wds:Q58376052-B355ECC4-CCE3-45AD-AFAE-3133FEED963B
author	Franklin G. Miller Steven Joffe
title	wds:Q58376052-D2758714-3E23-45E2-BBF7-5E86FD322DBB
title	Rethinking Risk-Benefit Assessment for Phase I Cancer Trials (en)
page(s)	wds:Q58376052-3331B23F-2D92-4186-9029-EA75447D2827
page(s)	2987-2990
instance of	wds:Q58376052-C6054D02-B2DE-4BEE-8670-55BC65E2A978
instance of	scholarly article
main subject	wds:Q58376052-4750E998-20A7-4354-ACCB-DE80B5074244
main subject	phase I clinical trial
PubMed ID	wds:Q58376052-3C9F6610-FAC7-4B41-969D-2B16F3C8697C
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16809725
PubMed ID	16809725
published in	wds:Q58376052-80F260BD-5DC8-4F07-8B30-6B6C86DD20B7
published in	Journal of Clinical Oncology
issue	wds:Q58376052-43551B64-DC89-40DC-B3F6-0A29066EDEA5
volume	wds:Q58376052-88C36A3D-7F25-456E-B156-DBDD19E6A9D8
issue	19
volume	24
DOI	wds:Q58376052-3EA6E4EF-493A-4649-A823-1E9A41CB16D5
DOI	http://dx.doi.org/10.1200/JCO.2005.04.9296
DOI	10.1200/JCO.2005.04.9296
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q58376052
is cites work of	The impact of an educational DVD on cancer patients considering participation in a phase I clinical trial Communication about the risks and benefits of phase I pediatric oncology trials The social value of clinical research The culture of faith and hope: patients' justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials Evaluation of statistical designs in phase I expansion cohorts: the Dana-Farber/Harvard Cancer Center experience. Phase I clinical trials: a call for papers Therapeutic misconception: hope, trust and misconception in paediatric research Phase I oncology studies: evidence that in the era of targeted therapies patients on lower doses do not fare worse Developing a Model of the Benefits and Burdens of Research Participation in Cancer Clinical Trials Extending clinical equipoise to phase 1 trials involving patients: unresolved problems Clinical trials and medical care: defining the therapeutic misconception Communication and informed consent in phase 1 trials: a review of the literature from January 2005 to July 2009. Melanoma patients in a phase I clinic: molecular aberrations, targeted therapy and outcomes. Early mortality and overall survival in oncology phase I trial participants: can we improve patient selection? Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials. Performing nondiagnostic research biopsies in irradiated tissue: a review of scientific, clinical, and ethical considerations Research biopsies in phase I studies: views and perspectives of participants and investigators Novel therapies, high-risk pediatric research, and the prospect of benefit: learning from the ethical disagreements A statistical evaluation of dose expansion cohorts in phase I clinical trials Principles of dose finding studies in cancer: a comparison of trial designs. Phase 0 clinical trials: conceptions and misconceptions The successful integration of research and care: how pediatric oncology became the subspecialty in which research defines the standard of care A Bayesian case study in oncology Phase I combination dose-finding using logistic regression with covariates Phase I trials involving radiation therapy, quantifying the risks. Investigator Disclosure and Advanced Cancer Patient Understanding of Informed Consent and Prognosis in Phase I Clinical Trials Flexible Phase I Clinical Trials: Allowing for Nonbinary Toxicity Response and Removal of Other Common Limitations Benefit in phase 1 oncology trials: therapeutic misconception or reasonable treatment option? Willingness to participate in HIV research at the end of life (EOL) Deliberation and the life cycle of informed consent. Phase 0 Clinical Trial Strategies for the Neurosurgical Oncologist Rethinking risk assessment for emerging technology first-in-human trials A population pharmacokinetic model of AT9283 in adults and children to predict the maximum tolerated dose in children with leukaemia Phase I oncology trials incorporating patient choice of dose Phase 1 oncology trials and informed consent Response to Commentaries Referrals to phase I clinical trials in a gynecologic oncology unit Ethical considerations for HIV cure-related research at the end of life Moral justification of Phase 1 oncology trials The complexity of consenting to clinical research in phase I pediatric cancer studies Ethical considerations and challenges in first-in-human research
is cites work of	wds:Q35496231-A0AB250A-A47F-4901-93A5-19A7A54DA752 wds:Q37687469-4B5FD8C1-D6AE-4D03-935C-1DC69D3ADE02 wds:Q36014074-D5C4290A-E847-4E7C-928E-EE1911DD7940 wds:Q54526137-4FDD6662-E194-4859-BA8A-B8034BCEF4DB wds:Q56545806-284B3338-C8D4-4E4D-9C81-6F9BE9025BDC wds:Q90414274-505023C6-618F-415D-AAB7-27F3E88B4054 wds:Q38972542-06057618-CD51-4B8D-8488-94FE777675AE wds:Q38974025-34D88068-BB06-4405-B299-5776B1CAA590 wds:Q40025547-E1A83885-8A0B-45A9-8079-527DAD6375A0 wds:Q58376040-DF844106-CF9B-49CE-9324-0DFD201ECDFF wds:Q85858083-4016E2A0-7DEE-4481-B361-C5801996148D wds:Q35788038-9508182E-A0F4-4958-A3FF-BE7C2E6684E2 wds:Q33714464-6FA46BD1-F4E9-45E4-93BF-9A7ADF9DAB76 wds:Q34251038-FA03373D-AC86-46AA-8862-0687FF8F7EBA wds:Q44378515-DF3311BD-0560-4DAB-B4ED-3B3A68C9EA3E wds:Q38312398-3A0EDE54-462B-44F4-B8D8-A484F7E848AD wds:Q36818341-5E6BC3FC-3175-45C8-A4DC-1B5F9AF15C07 wds:Q56786086-74B49AE0-25FE-4CA0-A449-198F730E7C4A

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software